Behavioral intervention
Recent articles
Owen’s odyssey: A year and a half after an autism diagnosis
This is part 2 of Owen’s story. It tracks his early progress in treatment for autism. Part 1 described his difficult path to a diagnosis.
Owen’s odyssey: A year and a half after an autism diagnosis
This is part 2 of Owen’s story. It tracks his early progress in treatment for autism. Part 1 described his difficult path to a diagnosis.
How autism researchers are applying machine-learning techniques
Researchers are using machine learning to improve diagnostic predictions of autism, create interactive support robots, and more.
How autism researchers are applying machine-learning techniques
Researchers are using machine learning to improve diagnostic predictions of autism, create interactive support robots, and more.
Explore more from The Transmitter
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.